Biosensors' profit takes a hit
MEDICAL device maker Biosensors International's net profit took a beating for both its fourth quarter and the full year, hit by lower revenue and thinner gross margins. Net profit for the three months ended March 31, 2014, was US$6.1 million, or 0.36 US cent per share, down from US$29.8 million, or 1.73 US cents per share, a year earlier.
Total revenue fell 8 per cent to US$81.6 million, partly due to a decline in revenues from interventional cardiology. The segment, Biosensor's largest product revenue contributor, recorded a 14 per cent decline in revenue to US$63 million.
Revenue from the group's other product segments - critical care and cardiac diagnostic - grew.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules
Nomura, Mizuho face losses on All Blue fund’s failed trades
Stablecoin Tether steps up monitoring in bid to combat illicit finance
HSBC asked by US$890 billion investor group to set energy goal
BHP’s biggest rivals sit on the sidelines of Anglo M&A drama